| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cartesian Therapeutics, Inc. (RNAC) has 13 insiders with recent SEC Form 4 filings, including 10 buys and 23 sells. RNAC is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 8.65M | $74.10M | - | |
| 10% | 511.6K | $4.38M | - | |
| CEO | 323.5K | $2.77M | - | |
| CFO | 121.2K | $1.04M | - | |
| Other | 94.2K | $807.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Brunn Carsten86 | President And CEO | Sell | 17,271 | $16.78 | $289,764.43 | -4.0% | -42.7% | -60.1% | |
| Jan 6, 2025 | Davis Blaine75 | Chief Financial Officer | Sell | 7,989 | $16.78 | $134,035.55 | -4.0% | -42.7% | -60.1% | |
| Jan 6, 2025 | Jewell Christopher M69 | Chief Scientific Officer | Sell | 2,550 | $16.78 | $42,782.69 | -2.3% | -42.7% | -60.1% | |
| Dec 23, 2024 | Springer Timothy A49 | Director, 10% Owner | Buy | 52,189 | $18.49 | $965,020.79 | +0.1% | -17.6% | -66.8% | |
| Dec 10, 2024 | Kurtoglu Metin80 | Chief Technology Officer | Sale+OE | 13,664 | $25.26 | $345,133.86 | -8.0% | -21.5% | -65.6% | |
| Nov 21, 2024 | Kurtoglu Metin80 | Chief Technology Officer | Sale+OE | 38,689 | $16.78 | $649,029.56 | -15.9% | +16.4% | -56.4% | |
| Nov 18, 2024 | Kurtoglu Metin80 | Chief Technology Officer | Sale+OE | 82,368 | $17.46 | $1,438,037.68 | -22.9% | +5.1% | -59.0% | |
| Nov 18, 2024 | Springer Timothy A49 | Director, 10% Owner | Buy | 431,940 | $17.07 | $7,373,527.21 | +1.1% | +5.1% | -59.0% | |
| Nov 15, 2024 | Miljkovic Milos73 | Chief Medical Officer | Sale+OE | 55,000 | $16.50 | $907,532.50 | -60.1% | +9.8% | -57.0% | |
| Nov 15, 2024 | Jewell Christopher M69 | Chief Scientific Officer | Sale+OE | 52,115 | $16.79 | $875,042.30 | -35.3% | +9.8% | -57.0% |